Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Balestier Investments is a Singapore-based investment holding company and a subsidiary of Temasek Holdings, the sovereign wealth fund of Singapore. The firm primarily functions as an investment vehicle through which Temasek manages and deploys capital into various sectors, with a significant focus on the life sciences, biotechnology, and healthcare industries. Balestier Investments has been involved in numerous high-profile funding rounds for innovative biotech companies globally, supporting the development of novel therapeutics and medical technologies. By leveraging its parent company's extensive resources, the firm plays a crucial role in the growth of the Singaporean and international biotech ecosystems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Balestier Investments.